Investigators

Find a Member

Full Investigator List

Finding the right member is just a click away.

Shivendra Singh

Shivendra Singh

Program: Cancer Epidemiology and Prevention

412-623-3262 singhs@upmc.edu 2.32A Hillman Cancer Research Pavilion
5117 Centre Ave
Pittsburgh PA
Summary

The primary research interests of the Singh laboratory include molecular characterization of novel cancer chemopreventive agents and rational design of mechanism-driven combination chemoprevention regimens. Cellular and transgenic animal models are used to screen potential cancer chemopreventive constituents from dietary and medicinal plants. Cutting edge cellular, molecular biological, omics (metabolomics and proteomics), structural biology, and imaging techniques (MRI and bioluminescence) are used to (a) determine the mechanism of action of promising cancer chemopreventive agents, (b) monitor effects on cancer progression, and (c) identify biomarkers predictive of tissue exposure and possibly response. Some of the agents under active investigation in the Singh laboratory include: cruciferous vegetable-derived isothiocyanates, garlic-derived organosulides, and medicinal plant constituent withaferin A. As an example, recent published work from the Singh laboratory indicates suppression of glycolysis in mammary cancer prevention by withaferin A in a transgenic mouse model. Likewise, complementary cellular and molecular biological, targeted proteomics, and molecular modeling techniques were used to identify beta-tubulin as a novel target of cancer cell growth arrest by withaferin A (WA).

Research Interests and Keywords
  • Cancer pharmacology
  • Cancer prevention
  • Chemoprevention
  • dietary anti-cancer compounds
  • Drug Discovery
  • isothiocynates
  • organosulides
  • withaferin A
Read More about Shivendra Singh

View Investigators by Last Name

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Top